Expiring contracts: AOK Baden-Württemberg
Contracts of this buyer that end between 30 Apr 2027 and 30 Apr 2028. Data as of 30 Oct 2026.
Portrait AOK Baden-Württemberg: contracts per year, sectors, regular contractors.
Contracts whose successor is being prepared now
Contracts for a recurring need whose notice states an end between 30 Apr 2027 and 30 Apr 2028: 58 contracts, 53 of them framework agreements. With the usual lead times, the new tender is being prepared now.
The list shows only services the buyer needs again after the contract ends, such as maintenance, cleaning, supplies or framework agreements. One-off projects such as a new building or a vehicle purchase are left out. Whether and when a contract is tendered again is the buyer's decision: contracts get extended, merged, or called off under framework agreements that TED does not show. The end date comes from the notice itself; contracts without a stated end are missing.
| Contract end | Sector | Subject | Current contractor |
|---|---|---|---|
| 30 Apr 2027 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zum Wirkstoff Guselkumab LOT-0001 | Janssen-Cilag GmbH |
| 30 Apr 2027 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zum Wirkstoff Ixekizumab LOT-0001 | Lilly Deutschland GmbH |
| 30 Apr 2027 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zu der Wirkstoffkombination Vilanterol und Umeclidiniumbromid LOT-0001 | BERLIN-CHEMIE AG |
| 30 Apr 2027 | Medical equipment and pharmaceuticals | Vereinbarung nach § 130a Abs. 8 SGB V i. V. m. § 130c Abs. 1 SGB V zum Wirkstoff Bevacizumab gamma (Lytenava™) LOT-0001 | Outlook Therapeutics Limited |
| 31 May 2027 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zu dem Wirkstoff Mepolizumab LOT-0001 | GlaxoSmithKline GmbH & Co. KG |
| 31 May 2027 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zu dem Wirkstoff Emicizumab LOT-0001 | Roche Pharma AG |
| 30 Jun 2027 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m. § 130a Abs. 8 SGB V zum Wirkstoff Romosozumab LOT-0001 | UCB Pharma GmbH |
| 30 Jun 2027 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m. § 130a Abs. 8 SGB V zum Wirkstoff Secukinumab LOT-0001 | Novartis Pharma GmbH |
| 30 Jun 2027 | Office and IT equipment | Anmietung eines Druck-/Kopiersystems inkl. Vollwartung | not stated |
| 30 Jun 2027 | IT services | AOK Mein Leben - Liefer- und Betriebsbasis für ePA-Anwendungen | not stated |
| 30 Jun 2027 | IT services | AOK Mein Leben - Liefer- und Betriebsbasis für ePA-Anwendungen 2 | not stated |
| 31 Jul 2027 | Cleaning, waste and environment | Glas-, Jalousie und Fassadenreinigung, Bezirksdirektion Hochrhein-Bodensee LOT-0004 | not shown |
| 31 Aug 2027 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V zum Wirkstoff Ofatumumab LOT-0001 | Novartis Pharma GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08AA01 - Amidotrizoesäure - Teillos 1 LOT-0001 | not stated |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08AA01 - Amidotrizoesäure - Teillos 2 LOT-0002 | not stated |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08AB04 - Iopamidol - Teillos 1 LOT-0008 | not stated |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08AA01 - Amidotrizoesäure - Teillos 3 LOT-0003 | Dr. Wolf, Beckelmann und Partner GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08AA05 - Ioxitalaminsäure LOT-0004 | Guerbet GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08AB02 - Iohexol - Teillos 1 LOT-0005 | GE Healthcare Buchler GmbH & Co. KG |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08AB02 - Iohexol - Teillos 2 LOT-0006 | GE Healthcare Buchler GmbH & Co. KG |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08AB02 - Iohexol - Teillos 3 LOT-0007 | GE Healthcare Buchler GmbH & Co. KG |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08AB04 - Iopamidol - Teillos 2 LOT-0009 | Bracco Imaging Deutschland GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08AB04 - Iopamidol - Teillos 3 LOT-0010 | b.e.imaging GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08AB05 - Iopromid - Teillos 1 LOT-0011 | Bayer Vital GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08AB05 - Iopromid - Teillos 2 LOT-0012 | Bayer Vital GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08AB07 - Ioversol LOT-0013 | Guerbet GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08AB09 - Iodixanol LOT-0014 | GE Healthcare Buchler GmbH & Co. KG |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08AB10 - Iomeprol LOT-0015 | Bracco Imaging Deutschland GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08AB11 - Iobitridol LOT-0016 | Guerbet GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08BA01 - Bariumsulfat LOT-0017 | Guerbet GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08CA12 - Gadopiclenol LOT-0018 | Guerbet GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08CA02 - Gadotersäure - Teillos 1 LOT-0019 | Guerbet GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08CA02 - Gadotersäure - Teillos 2 LOT-0020 | b.e.imaging GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08CA02 - Gadotersäure - Teillos 3 LOT-0021 | Guerbet GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08CA04 - Gadoteridol LOT-0022 | Bracco Imaging Deutschland GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08CA08 - Gadobensäure LOT-0023 | Bracco Imaging Deutschland GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08CA09 - Gadobutrol LOT-0024 | Bayer Vital GmbH |
| 30 Sep 2027 | Medical equipment and pharmaceuticals | V08CA10 - Gadoxetsäure LOT-0025 | Bayer Vital GmbH |
| 31 Oct 2027 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V zum Allergen-Extrakt aus Birkenpollen LOT-0001 | ALK Abelló Arzneimittel GmbH |
| 31 Oct 2027 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V zum Allergen-Extrakt aus Wiesenlieschgraspollen LOT-0001 | ALK Abelló Arzneimittel GmbH |
| 31 Oct 2027 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V zum Allergen-Extrakt aus Hausstaubmilben LOT-0001 | ALK Abelló Arzneimittel GmbH |
| 31 Oct 2027 | Repair and maintenance | Prüfung elektr. Anlagen und Geräte LOT-0001 | KPS Prüfservice GmbH |
| 31 Oct 2027 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V zum Wirkstoff Ciclosporin LOT-0001 | Théa Pharma GmbH |
| 31 Oct 2027 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zu der Wirkstoffkombination Aclidinium und Formoterolfumarat LOT-0001 | BERLIN-CHEMIE AG |
| 31 Dec 2027 | Medical equipment and pharmaceuticals | Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) LOT-0001 | not stated |
| 31 Dec 2027 | Medical equipment and pharmaceuticals | Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) LOT-0001 | not stated |
| 31 Dec 2027 | Medical equipment and pharmaceuticals | Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) LOT-0001 | not stated |
| 31 Dec 2027 | Medical equipment and pharmaceuticals | Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) LOT-0001 | not stated |
| 31 Dec 2027 | Medical equipment and pharmaceuticals | Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) LOT-0001 | not stated |
| 31 Dec 2027 | Medical equipment and pharmaceuticals | Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) LOT-0001 | not stated |
| 31 Dec 2027 | Medical equipment and pharmaceuticals | Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) LOT-0001 | not stated |
| 31 Jan 2028 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V mit der Wirkstoffkombination Beclometason / Formoterol / Glycopyrronium bromid LOT-0001 | Chiesi GmbH |
| 31 Jan 2028 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung nach § 130c Abs. 1 SGB V i. V. m. § 130a Abs. 8 SGB V zum Wirkstoff Filgotinib LOT-0001 | Alfasigma GmbH |
| 31 Mar 2028 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m. § 130a Abs. 8 SGB V zum Wirkstoff Apalutamid LOT-0001 | Janssen-Cilag GmbH |
| 30 Apr 2028 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zu der Wirkstofffixkombination Glecaprevir und Pibrentasvir LOT-0001 | AbbVie Deutschland GmbH & Co. KG |
| 30 Apr 2028 | Cleaning, waste and environment | Innenreinigung, Bezirksdirektion Stuttgart Böblingen Nord LOT-0001 | EBRA Gebäudedienstleistungen GmbH & Co. KG |
| 30 Apr 2028 | Cleaning, waste and environment | Innenreinigung, Bezirksdirektion Rhein-Neckar-Odenwald LOT-0006 | Peter Schneider Gebäudedienstleistungen GmbH & Co. KG |
| 30 Apr 2028 | Medical equipment and pharmaceuticals | Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V i. V. m. § 130c Abs. 1 SGB V zum Wirkstoff Depemokimab LOT-0001 | GlaxoSmithKline GmbH & Co. KG |
A report for your bid
This list shows every contract in the sector. For your company, we compile a report with only the contracts that match what you sell, across all sectors and federal states you bid in.
For each contract: term and extension options as stated in the notice, so the earliest and the latest date for a new tender. The contract value as stated in the notice, for framework agreements the maximum value. The history with the buyer: who won the contract before and how many bids came in. The award criteria of the last procedure. A person checks every report before it reaches you.
When a contract is tendered again, we support your bid: bid strategy, requirements matrix, writing the bid and submitting it on time. We work in German and English.